# Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

> **NCT04004754** · — · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 94 (actual)

## Conditions studied

- Cutaneous Leishmaniases

## Interventions

- **DRUG:** Miltefosine (administration is not part of study procedures)

## Key facts

- **NCT ID:** NCT04004754
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-07
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-06-11
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2020-06-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04004754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04004754, "Outcomes of Complicated CL in Ethiopia Treated With Miltefosine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04004754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*